Impact of early evidence of atherosclerotic changes on early treatment in children with familial hypercholesterolemia

Circulation Research

Volumn 114, Issue 2, 2014, Pages 233-235

  Reiner, Željko ^a  

^a UNIVERSITY OF ZAGREB   (Croatia)

Author keywords

Atherosclerosis; Carotid intima media thickness; Child; Editorials; Familial; Hydroxymethylglutaryl coa reductase inihibitors; Hypercholesterolemia; Hyperlipoproteinemia type II; Statins

Indexed keywords

ANTILIPEMIC AGENT; APOLIPOPROTEIN B; EZETIMIBE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN RECEPTOR; MICROSOMAL TRIGLYCERIDE TRANSFER PROTEIN INHIBITOR;

ANKLE BRACHIAL INDEX; ARTERIAL WALL THICKNESS; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; CARDIOVASCULAR RISK; CAROTID ARTERY; CHILD; FAMILIAL HYPERCHOLESTEROLEMIA; HUMAN; PRIORITY JOURNAL; REVIEW; CAROTID ARTERY DISEASE; ECHOGRAPHY; EDITORIALS; FEMALE; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INIHIBITORS, STATINS; MALE; NOTE;

ATHEROSCLEROSIS; CAROTID INTIMA-MEDIA THICKNESS; CHILD; EDITORIALS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INIHIBITORS, STATINS; HYPERCHOLESTEROLEMIA, FAMILIAL; HYPERLIPOPROTEINEMIA TYPE II;

CAROTID ARTERIES; CAROTID ARTERY DISEASES; CAROTID INTIMA-MEDIA THICKNESS; FEMALE; HUMANS; HYPERLIPOPROTEINEMIA TYPE II; MALE;

EID: 84897116140     PISSN: 00097330     EISSN: 15244571     Source Type: Journal    
DOI: 10.1161/CIRCRESAHA.113.302952     Document Type: Review

References (23)

1. Reiner Ž, Catapano AL, De Backer G, et al. ESC/EAS Guidelines for the management of dyslipidaemias: The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS). Eur Heart J. 2011;32:1769-1818.
2. Whittall RA, Scartezini M, Li K, Hubbart C, Reiner Z, Abraha A, Neil HA, Dedoussis G, Humphries SE. Development of a high-resolution melting method for mutation detection in familial hypercholesterolaemia patients. Ann Clin Biochem. 2010;47:44-55.
3. Pećin I, Whittall R, Futema M, Sertić J, Reiner Z, Leigh SE, Humphries SE. Mutation detection in Croatian patients with familial hypercholesterolemia. Ann Hum Genet. 2013;77:22-30.
4. Nordestgaard BG, Chapman MJ, Humphries SE, et al.; European Atherosclerosis Society Consensus Panel. Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease: Consensus Statement of the European Atherosclerosis Society. Eur Heart J. 2013;34:3478-3490.
5. Expert Panel on Integrated Guidelines for Cardiovascular Health and Risk Reduction in Children and Adolescents; National Heart, Lung, and Blood Institute. Expert panel on integrated guidelines for cardiovascular health and risk reduction in children and adolescents: summary report. Pediatrics. 2011;128:213-256.
6. Kusters DM, Wiegman A, Kastelein JJ, Hutten BA. Carotid intima-media thickness in children with familial hypercholesterolemia. Circ Res. 2014:114:307-310.
7. Perk J, De Backer G, Gohlke H, et al. European Guidelines on cardiovascular disease prevention in clinical practice (version 2012). Euro Heart J. 2012;33;1635-1701.
8. Perrone-Filardi P, Achenbach S, Möhlenkamp S, Reiner Z, Sambuceti G, Schuijf JD, Van der Wall E, Kaufmann PA, Knuuti J, Schroeder S, Zellweger MJ. Cardiac computed tomography and myocardial perfusion scintigraphy for risk stratification in asymptomatic individuals without known cardiovascular disease: A position statement of the Working Group on Nuclear Cardiology and Cardiac CT of the European Society of Cardiology. Eur Heart J. 2011;32:1986-1993, 1993, 1993b.
9. Zannad F, De Backer G, Graham I, Lorenz M, Mancia G, Morrow DA, Reiner Z, Koenig W, Dallongeville J, Macfadyen RJ, Ruilope LM, Wilhelmsen L; ESC Working Group on CardioVascular Pharmacology and Drug Therapy. Risk stratification in cardiovascular disease primary prevention-scoring systems, novel markers, and imaging techniques. Fundam Clin Pharmacol. 2012;26:163-174.
10. Reiner Ž. Statins for primary prevention: problems with cardiovascular-risk estimation? Nat Rev Cardiol. 2013;10:547.
11. Lavrencic A, Kosmina B, Keber I, Videcnik V, Keber D. Carotid intima-media thickness in young patients with familial hypercholesterolaemia. Heart. 1996;76:321-325.
12. Juonala M, Magnussen CG, Venn A, Dwyer T, Burns TL, Davis PH, Chen W, Srinivasan SR, Daniels SR, Kähönen M, Laitinen T, Taittonen L, Berenson GS, Viikari JS, Raitakari OT. Influence of age on associations between childhood risk factors and carotid intima-media thickness in adulthood: The Cardiovascular Risk in Young Finns Study, the Childhood Determinants of Adult Health Study, the Bogalusa Heart Study, and the Muscatine Study for the International Childhood Cardiovascular Cohort (i3C) Consortium. Circulation. 2010;122:2514-2520.
13. Raitakari OT, Juonala M, Rönnemaa T, et al. Cohort profile: The cardiovascular risk in Young Finns Study. Int J Epidemiol. 2008;37:1220-1226.
14. de Jongh S, Lilien MR, op't Roodt J, Stroes ES, Bakker HD, Kastelein JJ. Early statin therapy restores endothelial function in children with familial hypercholesterolemia. J Am Coll Cardiol. 2002;40:2117-2121.
15. Wiegman A, Hutten BA, de Groot E, Rodenburg J, Bakker HD, Büller HR, Sijbrands EJ, Kastelein JJ. Efficacy and safety of statin therapy in children with familial hypercholesterolemia: A randomized controlled trial. JAMA. 2004;292:331-337.
16. Rodenburg J, Vissers MN, Wiegman A, van Trotsenburg AS, van der Graaf A, de Groot E, Wijburg FA, Kastelein JJ, Hutten BA. Statin treatment in children with familial hypercholesterolemia: The younger, the better. Circulation. 2007;116:664-668.
17. Reiner Ž. Statins in the primary prevention of cardiovascular disease. Nat Rev Cardiol. 2013;10:453-464.
18. Natural history of aortic and coronary atherosclerotic lesions in youth. Findings from the PDAY Study. Pathobiological Determinants of Atherosclerosis in Youth (PDAY) Research Group. Arterioscler Thromb. 1993;13:1291-1298.
19. Li S, Chen W, Srinivasan SR, Bond MG, Tang R, Urbina EM, Berenson GS. Childhood cardiovascular risk factors and carotid vascular changes in adulthood: The Bogalusa Heart Study. JAMA. 2003;290:2271-2276.
20. Berenson GS, Srinivasan SR, Bao W, Newman WP 3rd, Tracy RE, Wattigney WA. Association between multiple cardiovascular risk factors and atherosclerosis in children and young adults. The Bogalusa Heart Study. N Engl J Med. 1998;338:1650-1656.
21. Dumić M, Uroic AS, Francetić I, Puretić Z, Matisić D, Kes P, Mikecin M, Reiner Z. [Three-year-old boy-a homozygote for familiar hypercholesterolemia]. Lijec Vjesn. 2007;129:130-133.
22. Avis HJ, Hutten BA, Gagné C, Langslet G, McCrindle BW, Wiegman A, Hsia J, Kastelein JJ, Stein EA. Efficacy and safety of rosuvastatin therapy for children with familial hypercholesterolemia. J Am Coll Cardiol. 2010;55:1121-1126.
23. Reiner Ž. Managing the residual cardiovascular disease risk associated with HDL-cholesterol and triglycerides in statin-treated patients: A clinical update. Nutr Metab Cardiovasc Dis. 2013;23:799-807.